Cargando…
Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma
Dickkopf-1 (DKK1) is an ideal target for the immunotherapy of multiple myeloma. Heat Shock protein70 (HSP70) is a class of important molecular chaperone to promote antigen presentation. Homologous xenogeneic antigens can enhance immunogenicity and induce stronger anti-tumor immune response than that...
Autores principales: | Liu, Ting-Ting, Wu, Yang, Niu, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787455/ https://www.ncbi.nlm.nih.gov/pubmed/29416605 http://dx.doi.org/10.18632/oncotarget.23352 |
Ejemplares similares
-
Identification of an immunogenic DKK1 long peptide for immunotherapy of human multiple myeloma
por: Li, Rong, et al.
Publicado: (2020) -
Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma
por: Eugênio, Angela Isabel Pereira, et al.
Publicado: (2017) -
The anti-inflammatory mechanisms of Hsp70
por: Borges, Thiago J., et al.
Publicado: (2012) -
Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma
por: Dun, Xiaoyi, et al.
Publicado: (2010) -
DKK1 as a novel target for myeloma immunotherapy
por: Qian, Jianfei, et al.
Publicado: (2012)